+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Fibrinogen Testing Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • PDF Icon

    Report

  • 247 Pages
  • December 2023
  • Region: Global
  • Fairfield Market Research
  • ID: 5916042
Description Jump to:
The global Fibrinogen Testing market is poised for exponential growth between 2024 and 2031, driven by a host of key factors that underscore its significance in healthcare. Fibrinogen, a crucial glycoprotein in the body essential for blood circulation, is undergoing a surge in testing due to its pivotal role in managing various health conditions, including diabetes and blood clotting disorders. This market is projected to reach USD 300 Million by 2031, up from USD 195 Million in 2024.

Key Drivers to the Fibrinogen Testing Market

1. Increase in the Prevalence of Chronic Diseases: The escalating prevalence of chronic diseases such as diabetes, closely linked to blood clotting issues, is driving the demand for fibrinogen testing. As the global population grapples with lifestyle disorders, monitoring fibrinogen levels in the blood becomes critical for timely intervention.

2. Increased Prevalence of Blood Clotting Disorders: A growing number of individuals are affected by blood clotting disorders, necessitating regular fibrinogen testing. Additionally, increased healthcare spending and new market entrants are stimulating market growth.

3. Increased Adoption of Coagulation Instruments and Reagents: The adoption of advanced coagulation instruments and reagents, catering to the need for rapid and efficient testing, is on the rise. Privatization of diagnostic laboratories to offer enhanced services is further bolstering market growth.

4. An Increase in Anticoagulant Therapy Procedures: Anticoagulant therapies, both traditional and novel, are extensively used for various clotting disorders. Consistent blood tests, including fibrinogen testing, are essential to gauge the effectiveness of these therapies, driving market expansion.

Restraints on the Fibrinogen Testing Market

High Cost of Equipment & Low Awareness: The cost associated with fibrinogen testing equipment limits its accessibility primarily to major healthcare institutes and labs. This cost barrier may hinder market growth. Additionally, a lack of awareness in developing countries presents a challenge to unlocking the market's full potential.

Impact of COVID-19 on Fibrinogen Testing Market

The COVID-19 pandemic brought about significant disruptions in the Fibrinogen Testing market. Lockdowns and supply chain interruptions led to a temporary decline in testing. However, as the situation improved and restrictions eased, the demand for Fibrinogen Testing rebounded, underscoring its resilience in the face of adversity.

Competitive Landscape

The Fibrinogen Testing Market is highly competitive, featuring numerous prominent players. Major industry leaders are focused on diversifying their product offerings to enhance revenue and market share.

Key Companies Profiled

  • Thermo Fisher Scientific Inc.
  • Grifols
  • Helena Laboratories Corporation
  • Stago
  • TULIP DIAGNOSTICS (P) LTD
  • Werfen
  • Biosystems S.A.
  • Randox Laboratories Ltd.
  • Technoclone
  • Medirox AB
  • MedTest
  • Enzyme Research Laboratories (r2 Diagnostics)
  • Kamiya biomedical Company
  • Pathway Diagnostics Limited

Fibrinogen Testing Market Segmentation

Fibrinogen Testing Market by Reagent Type

  • Q.F.A. Thrombin Kits
  • Fibrinogen Kits
  • Multifibren U Kits
  • STA-fibrinogen Kits
  • Imidazole Buffer Kits

Fibrinogen Testing Market by Indication

  • Congenital Fibrinogen Disorders
  • Fibrinogen storage disease
  • Hereditary fibrinogen Aα-Chain amyloidosis,
  • Acquired dysfibrinogenemia
  • Cryofibrinogenemia
  • Disseminated Intravascular Coagulation (DIC)
  • End-Stage Liver Disease

Fibrinogen Testing Market by End User

  • Hospitals
  • Clinics
  • Diagnostic Laboratories
  • Ambulatory Care Centers
  • Academics & Research Institutes

Fibrinogen Testing Market by Region

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa (MEA)


This product will be delivered within 1-3 business days.

Table of Contents

1. Executive Summary
1.1. Global Fibrinogen Testing Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value and Volume, 2023
1.5. Analyst Recommendations
2. Market Overview
2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter’s Five Forces Analysis
2.5. COVID-19 Impact Analysis
2.5.1. Supply
2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
2.7.1. World Economic Projections
2.8. PESTLE Analysis
3. Price Analysis, 2018 - 2023
3.1. Global Average Price Analysis, by Reagent/ Application, US$ Per Unit, 2018 - 2023
3.2. Prominent Factor Affecting Breast Tissue Markers Prices
3.3. Global Average Price Analysis, by Region, US$ Per Unit
4. Global Fibrinogen Testing Market Outlook, 2018 - 2031
4.1. Global Fibrinogen Testing Market Outlook, by Reagent, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
4.1.1. Key Highlights
4.1.1.1. Q.F.A. Thrombin Kits
4.1.1.2. Fibrinogen Kits
4.1.1.3. Multifibren U Kits
4.1.1.4. STA-fibrinogen Kits
4.1.1.5. Imidazole Buffer Kits
4.2. Global Fibrinogen Testing Market Outlook, by Indication, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
4.2.1. Key Highlights
4.2.1.1. Congenital Fibrinogen Disorders
4.2.1.2. Fibrinogen storage disease
4.2.1.3. Hereditary fibrinogen Aa-Chain amyloidosis,
4.2.1.4. Acquired dysfibrinogenemia
4.2.1.5. Cryofibrinogenemia
4.2.1.6. Disseminated Intravascular Coagulation (DIC)
4.2.1.7. End-Stage Liver Disease
4.3. Global Fibrinogen Testing Market Outlook, by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
4.3.1. Key Highlights
4.3.1.1. Hospitals
4.3.1.2. Clinics
4.3.1.3. Diagnostic Laboratories
4.3.1.4. Ambulatory Care Centres
4.3.1.5. Academics & Research Institutes
4.4. Global Fibrinogen Testing Market Outlook, by Region, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
4.4.1. Key Highlights
4.4.1.1. North America
4.4.1.2. Europe
4.4.1.3. Asia Pacific
4.4.1.4. Latin America
4.4.1.5. Middle East & Africa
5. North America Fibrinogen Testing Market Outlook, 2018 - 2031
5.1. North America Fibrinogen Testing Market Outlook, by Reagent, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
5.1.1. Key Highlights
5.1.1.1. Q.F.A. Thrombin Kits
5.1.1.2. Fibrinogen Kits
5.1.1.3. Multifibren U Kits
5.1.1.4. STA-fibrinogen Kits
5.1.1.5. Imidazole Buffer Kits
5.2. North America Fibrinogen Testing Market Outlook, by Indication, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
5.2.1. Key Highlights
5.2.1.1. Congenital Fibrinogen Disorders
5.2.1.2. Fibrinogen storage disease
5.2.1.3. Hereditary fibrinogen Aa-Chain amyloidosis,
5.2.1.4. Acquired dysfibrinogenemia
5.2.1.5. Cryofibrinogenemia
5.2.1.6. Disseminated Intravascular Coagulation (DIC)
5.2.1.7. End-Stage Liver Disease
5.3. North America Fibrinogen Testing Market Outlook, by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
5.3.1. Key Highlights
5.3.1.1. Hospitals
5.3.1.2. Clinics
5.3.1.3. Diagnostic Laboratories
5.3.1.4. Ambulatory Care Centres
5.3.1.5. Academics & Research Institutes
5.4. North America Fibrinogen Testing Market Outlook, by Country, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
5.4.1. Key Highlights
5.4.1.1. U.S. Fibrinogen Testing Market by Reagent, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
5.4.1.2. U.S. Fibrinogen Testing Market by Indication, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
5.4.1.3. U.S. Fibrinogen Testing Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
5.4.1.4. Canada Fibrinogen Testing Market by Reagent, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
5.4.1.5. Canada Fibrinogen Testing Market by Indication, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
5.4.1.6. Canada Fibrinogen Testing Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
5.4.2. BPS Analysis/Market Attractiveness Analysis
6. Europe Fibrinogen Testing Market Outlook, 2018 - 2031
6.1. Europe Fibrinogen Testing Market Outlook, by Reagent, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
6.1.1. Key Highlights
6.1.1.1. Q.F.A. Thrombin Kits
6.1.1.2. Fibrinogen Kits
6.1.1.3. Multifibren U Kits
6.1.1.4. STA-fibrinogen Kits
6.1.1.5. Imidazole Buffer Kits
6.2. Europe Fibrinogen Testing Market Outlook, by Indication, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
6.2.1. Key Highlights
6.2.1.1. Congenital Fibrinogen Disorders
6.2.1.2. Fibrinogen storage disease
6.2.1.3. Hereditary fibrinogen Aa-Chain amyloidosis,
6.2.1.4. Acquired dysfibrinogenemia
6.2.1.5. Cryofibrinogenemia
6.2.1.6. Disseminated Intravascular Coagulation (DIC)
6.2.1.7. End-Stage Liver Disease
6.3. Europe Fibrinogen Testing Market Outlook, by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
6.3.1. Key Highlights
6.3.1.1. Hospitals
6.3.1.2. Clinics
6.3.1.3. Diagnostic Laboratories
6.3.1.4. Ambulatory Care Centres
6.3.1.5. Academics & Research Institutes
6.4. Europe Fibrinogen Testing Market Outlook, by Country, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
6.4.1. Key Highlights
6.4.1.1. Germany Fibrinogen Testing Market by Reagent, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
6.4.1.2. Germany Fibrinogen Testing Market by Indication, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
6.4.1.3. Germany Fibrinogen Testing Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
6.4.1.4. U.K. Fibrinogen Testing Market by Reagent, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
6.4.1.5. U.K. Fibrinogen Testing Market by Indication, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
6.4.1.6. U.K. Fibrinogen Testing Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
6.4.1.7. France Fibrinogen Testing Market by Reagent, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
6.4.1.8. France Fibrinogen Testing Market by Indication, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
6.4.1.9. France Fibrinogen Testing Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
6.4.1.10. Italy Fibrinogen Testing Market by Reagent, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
6.4.1.11. Italy Fibrinogen Testing Market by Indication, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
6.4.1.12. Italy Fibrinogen Testing Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
6.4.1.13. Turkey Fibrinogen Testing Market by Reagent, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
6.4.1.14. Turkey Fibrinogen Testing Market by Indication, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
6.4.1.15. Turkey Fibrinogen Testing Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
6.4.1.16. Russia Fibrinogen Testing Market by Reagent, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
6.4.1.17. Russia Fibrinogen Testing Market by Indication, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
6.4.1.18. Russia Fibrinogen Testing Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
6.4.1.19. Rest of Europe Fibrinogen Testing Market by Reagent, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
6.4.1.20. Rest of Europe Fibrinogen Testing Market by Indication, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
6.4.1.21. Rest of Europe Fibrinogen Testing Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
6.4.2. BPS Analysis/Market Attractiveness Analysis
7. Asia Pacific Fibrinogen Testing Market Outlook, 2018 - 2031
7.1. Asia Pacific Fibrinogen Testing Market Outlook, by Reagent, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
7.1.1. Key Highlights
7.1.1.1. Q.F.A. Thrombin Kits
7.1.1.2. Fibrinogen Kits
7.1.1.3. Multifibren U Kits
7.1.1.4. STA-fibrinogen Kits
7.1.1.5. Imidazole Buffer Kits
7.2. Asia Pacific Fibrinogen Testing Market Outlook, by Indication, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
7.2.1. Key Highlights
7.2.1.1. Congenital Fibrinogen Disorders
7.2.1.2. Fibrinogen storage disease
7.2.1.3. Hereditary fibrinogen Aa-Chain amyloidosis,
7.2.1.4. Acquired dysfibrinogenemia
7.2.1.5. Cryofibrinogenemia
7.2.1.6. Disseminated Intravascular Coagulation (DIC)
7.2.1.7. End-Stage Liver Disease
7.3. Asia Pacific Fibrinogen Testing Market Outlook, by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
7.3.1. Key Highlights
7.3.1.1. Hospitals
7.3.1.2. Clinics
7.3.1.3. Diagnostic Laboratories
7.3.1.4. Ambulatory Care Centres
7.3.1.5. Academics & Research Institutes
7.4. Asia Pacific Fibrinogen Testing Market Outlook, by Country, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
7.4.1. Key Highlights
7.4.1.1. China Fibrinogen Testing Market by Reagent, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
7.4.1.2. China Fibrinogen Testing Market by Indication, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
7.4.1.3. China Fibrinogen Testing Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
7.4.1.4. Japan Fibrinogen Testing Market by Reagent, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
7.4.1.5. Japan Fibrinogen Testing Market by Indication, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
7.4.1.6. Japan Fibrinogen Testing Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
7.4.1.7. South Korea Fibrinogen Testing Market by Reagent, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
7.4.1.8. South Korea Fibrinogen Testing Market by Indication, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
7.4.1.9. South Korea Fibrinogen Testing Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
7.4.1.10. India Fibrinogen Testing Market by Reagent, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
7.4.1.11. India Fibrinogen Testing Market by Indication, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
7.4.1.12. India Fibrinogen Testing Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
7.4.1.13. Southeast Asia Fibrinogen Testing Market by Reagent, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
7.4.1.14. Southeast Asia Fibrinogen Testing Market by Indication, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
7.4.1.15. Southeast Asia Fibrinogen Testing Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
7.4.1.16. Rest of Asia Pacific Fibrinogen Testing Market by Reagent, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
7.4.1.17. Rest of Asia Pacific Fibrinogen Testing Market by Indication, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
7.4.1.18. Rest of Asia Pacific Fibrinogen Testing Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
7.4.2. BPS Analysis/Market Attractiveness Analysis
8. Latin America Fibrinogen Testing Market Outlook, 2018 - 2031
8.1. Latin America Fibrinogen Testing Market Outlook, by Reagent, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
8.1.1. Key Highlights
8.1.1.1. Q.F.A. Thrombin Kits
8.1.1.2. Fibrinogen Kits
8.1.1.3. Multifibren U Kits
8.1.1.4. STA-fibrinogen Kits
8.1.1.5. Imidazole Buffer Kits
8.2. Latin America Fibrinogen Testing Market Outlook, by Indication, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
8.2.1.1. Congenital Fibrinogen Disorders
8.2.1.2. Fibrinogen storage disease
8.2.1.3. Hereditary fibrinogen Aa-Chain amyloidosis,
8.2.1.4. Acquired dysfibrinogenemia
8.2.1.5. Cryofibrinogenemia
8.2.1.6. Disseminated Intravascular Coagulation (DIC)
8.2.1.7. End-Stage Liver Disease
8.3. Latin America Fibrinogen Testing Market Outlook, by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
8.3.1. Key Highlights
8.3.1.1. Hospitals
8.3.1.2. Clinics
8.3.1.3. Diagnostic Laboratories
8.3.1.4. Ambulatory Care Centres
8.3.1.5. Academics & Research Institutes
8.4. Latin America Fibrinogen Testing Market Outlook, by Country, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
8.4.1. Key Highlights
8.4.1.1. Brazil Fibrinogen Testing Market by Reagent, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
8.4.1.2. Brazil Fibrinogen Testing Market by Indication, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
8.4.1.3. Brazil Fibrinogen Testing Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
8.4.1.4. Mexico Fibrinogen Testing Market by Reagent, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
8.4.1.5. Mexico Fibrinogen Testing Market by Indication, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
8.4.1.6. Mexico Fibrinogen Testing Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
8.4.1.7. Argentina Fibrinogen Testing Market by Reagent, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
8.4.1.8. Argentina Fibrinogen Testing Market by Indication, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
8.4.1.9. Argentina Fibrinogen Testing Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
8.4.1.10. Rest of Latin America Fibrinogen Testing Market by Reagent, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
8.4.1.11. Rest of Latin America Fibrinogen Testing Market by Indication, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
8.4.1.12. Rest of Latin America Fibrinogen Testing Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
8.4.2. BPS Analysis/Market Attractiveness Analysis
9. Middle East & Africa Fibrinogen Testing Market Outlook, 2018 - 2031
9.1. Middle East & Africa Fibrinogen Testing Market Outlook, by Reagent, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
9.1.1. Key Highlights
9.1.1.1. Q.F.A. Thrombin Kits
9.1.1.2. Fibrinogen Kits
9.1.1.3. Multifibren U Kits
9.1.1.4. STA-fibrinogen Kits
9.1.1.5. Imidazole Buffer Kits
9.2. Middle East & Africa Fibrinogen Testing Market Outlook, by Indication, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
9.2.1. Key Highlights
9.2.1.1. Scientific Research
9.2.1.2. Medical Diagnostics
9.2.1.3. Agricultural Application
9.2.1.4. Food & Beverages
9.2.1.5. Other Applications
9.3. Middle East & Africa Fibrinogen Testing Market Outlook, by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
9.3.1. Key Highlights
9.3.1.1. Hospitals
9.3.1.2. Clinics
9.3.1.3. Diagnostic Laboratories
9.3.1.4. Ambulatory Care Centres
9.3.1.5. Academics & Research Institutes
9.4. Middle East & Africa Fibrinogen Testing Market Outlook, by Country, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
9.4.1. Key Highlights
9.4.1.1. GCC Fibrinogen Testing Market by Reagent, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
9.4.1.2. GCC Fibrinogen Testing Market by Indication, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
9.4.1.3. GCC Fibrinogen Testing Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
9.4.1.4. South Africa Fibrinogen Testing Market by Reagent, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
9.4.1.5. South Africa Fibrinogen Testing Market by Indication, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
9.4.1.6. South Africa Fibrinogen Testing Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
9.4.1.7. Egypt Fibrinogen Testing Market by Reagent, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
9.4.1.8. Egypt Fibrinogen Testing Market by Indication, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
9.4.1.9. Egypt Fibrinogen Testing Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
9.4.1.10. Nigeria Fibrinogen Testing Market by Reagent, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
9.4.1.11. Nigeria Fibrinogen Testing Market by Indication, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
9.4.1.12. Nigeria Fibrinogen Testing Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
9.4.1.13. Rest of Middle East & Africa Fibrinogen Testing Market by Reagent, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
9.4.1.14. Rest of Middle East & Africa Fibrinogen Testing Market by Indication, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
9.4.1.15. Rest of Middle East & Africa Fibrinogen Testing Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
9.4.2. BPS Analysis/Market Attractiveness Analysis
10. Competitive Landscape
10.1. Artery Type vs Indication Heatmap
10.2. Manufacturer vs Indication Heatmap
10.3. Company Market Share Analysis, 2023
10.4. Competitive Dashboard
10.5. Company Profiles
10.5.1. Thermo Fisher Scientific Inc.
10.5.1.1. Company Overview
10.5.1.2. Product Portfolio
10.5.1.3. Financial Overview
10.5.1.4. Business Strategies and Development
10.5.2. Grifols
10.5.2.1. Company Overview
10.5.2.2. Product Portfolio
10.5.2.3. Financial Overview
10.5.2.4. Business Strategies and Development
10.5.3. Helena Laboratories Corporation
10.5.3.1. Company Overview
10.5.3.2. Product Portfolio
10.5.3.3. Financial Overview
10.5.3.4. Business Strategies and Development
10.5.4. Stago
10.5.4.1. Company Overview
10.5.4.2. Product Portfolio
10.5.4.3. Financial Overview
10.5.4.4. Business Strategies and Development
10.5.5. TULIP DIAGNOSTICS (P) LTD
10.5.5.1. Company Overview
10.5.5.2. Product Portfolio
10.5.5.3. Financial Overview
10.5.5.4. Business Strategies and Development
10.5.6. Werfen
10.5.6.1. Company Overview
10.5.6.2. Product Portfolio
10.5.6.3. Financial Overview
10.5.6.4. Business Strategies and Development
10.5.7. Biosystems S.A.
10.5.7.1. Company Overview
10.5.7.2. Product Portfolio
10.5.7.3. Financial Overview
10.5.7.4. Business Strategies and Development
10.5.8. Randox Laboratories Ltd.
10.5.8.1. Company Overview
10.5.8.2. Product Portfolio
10.5.8.3. Financial Overview
10.5.8.4. Business Strategies and Development
10.5.9. Technoclone
10.5.9.1. Company Overview
10.5.9.2. Product Portfolio
10.5.9.3. Financial Overview
10.5.9.4. Business Strategies and Development
10.5.10. Medirox AB
10.5.10.1. Company Overview
10.5.10.2. Product Portfolio
10.5.10.3. Financial Overview
10.5.10.4. Business Strategies and Development
10.5.11. MedTest
10.5.11.1. Company Overview
10.5.11.2. Product Portfolio
10.5.11.3. Financial Overview
10.5.11.4. Business Strategies and Development
11. Appendix
11.1. Research Methodology
11.2. Report Assumptions
11.3. Acronyms and Abbreviations

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Siemens Healthcare GmbH)
  • Thermo Fisher Scientific Inc.
  • Grifols
  • Helena Laboratories Corporation
  • Stago
  • TULIP DIAGNOSTICS (P) LTD
  • Werfen
  • Biosystems S.A.
  • Randox Laboratories Ltd.
  • Technoclone
  • Medirox AB
  • MedTest
  • Enzyme Research Laboratories(r2 Diagnostics)
  • Kamiya biomedical Company
  • Pathway Diagnostics Limited

Methodology

Loading
LOADING...

Related Topics

Related Reports

Fibrinogen Testing Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type - Product Image

Fibrinogen Testing Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • 82 Pages
  • Global
From
Global Coagulation & Hemostasis Testing Market by Test Type (Activated Partial Thromboplastin Time, D-Dimer Testing, Fibrinogen Testing), Technology (Electrochemical Technology, Mechanical Technology, Optical Technology), End-Use - Forecast 2024-2030 - Product Image

Global Coagulation & Hemostasis Testing Market by Test Type (Activated Partial Thromboplastin Time, D-Dimer Testing, Fibrinogen Testing), Technology (Electrochemical Technology, Mechanical Technology, Optical Technology), End-Use - Forecast 2024-2030

  • Report
  • 197 Pages
  • Global
From
Coagulation Analyzer Market Report by Testing Type, Product Type, Technology Type, End User, and Region 2024-2032 - Product Image

Coagulation Analyzer Market Report by Testing Type, Product Type, Technology Type, End User, and Region 2024-2032

  • Report
  • 139 Pages
  • Global
From
Hemostasis Diagnostics: Global Strategic Business Report - Product Image

Hemostasis Diagnostics: Global Strategic Business Report

  • Report
  • 173 Pages
  • Global
From
2024 Global Hemostasis Analyzers and Reagents - USA, Europe, Japan - Chromogenic, Immunodiagnostic, Molecular Coagulation Test Volume and Sales Segment Forecasts for Hospitals, Commercial/Private Labs and POC Locations - Product Image

2024 Global Hemostasis Analyzers and Reagents - USA, Europe, Japan - Chromogenic, Immunodiagnostic, Molecular Coagulation Test Volume and Sales Segment Forecasts for Hospitals, Commercial/Private Labs and POC Locations

  • Report
  • Europe, Global, Japan, ... Europe, Global, Japan, United States
From

About the Fibrinogen Testing Market

Fibrinogen testing is a type of coagulation and hemostasis testing used to measure the amount of fibrinogen in the blood. Fibrinogen is a protein that helps the body form blood clots. Low levels of fibrinogen can lead to excessive bleeding, while high levels can lead to clotting disorders. Fibrinogen testing is used to diagnose and monitor conditions such as liver disease, disseminated intravascular coagulation, and von Willebrand disease. It is also used to monitor the effectiveness of anticoagulant therapy. The fibrinogen testing market is composed of a variety of companies that provide products and services related to the testing of fibrinogen. These include manufacturers of reagents, instruments, and consumables, as well as companies that provide laboratory services. Examples of companies in the market include Siemens Healthineers, Abbott Laboratories, Roche Diagnostics, Sysmex Corporation, and Ortho Clinical Diagnostics. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.